I am a Senior Digital Consultant passionate about driving digital transformation in the manufacturing industry. I began my career as a system engineer, working with industrial automation, OT/IT integration, and infrastructure. Over time, I moved into a senior consulting role where I guide manufacturers through complex transformation initiatives that align technology, business objectives, and regulatory requirements.

I help manufacturers solve what I see as high-stakes puzzles—where Unified Namespace architectures, MES and EBR systems, and workflow optimization must all fit together to deliver measurable outcomes.

Notable projects include the deployment of Electronic Batch Record systems that reduced Master Batch Records by 60% and accelerated batch release times by 30%, as well as digital roadmaps that standardized operations across multiple sites. My expertise spans Industry 4.0, Pharma 4.0, MES MOM, and smart manufacturing.

I believe digital transformation isn’t just about efficiency—it’s about revitalizing industries, creating jobs in Europe, and fostering long-term resilience in a rapidly evolving world.

With over six years of experience in the biopharmaceutical industry, Jesse Daneels has built a cross-functional career grounded in strong technical expertise. He started as a system engineer, supporting infrastructure and operations in highly regulated GxP environments. He later moved into roles such as Technical Service Owner (TSO), Computerized System Validation (CSV) engineer, and subject matter expert—gaining deep knowledge of compliance, data integrity, and system lifecycle management.

Jesse’s path gradually shifted toward strategic roles, including project manager and business analyst, where he led cross-functional teams and helped translate business needs into technical solutions. His focus has consistently been on delivering validated systems that align operational performance with regulatory requirements.

As a TSO, Jesse has overseen the reliability and continuous improvement of critical IT systems within global operations. He is recognized for his analytical thinking, collaborative mindset, and clear communication.

Jesse is passionate about digital transformation, process optimization, and contributing to innovations that enhance product quality and patient outcomes.

The Pop in Your Job: What drives me most is knowing that the work I do has a real, tangible impact on people’s lives. In the biopharmaceutical industry, every improvement we make—whether in system design, validation, or process optimization—ultimately supports the delivery of safe, high-quality therapies to patients who need them. That’s a powerful motivator.

I love solving complex problems, and working in manufacturing systems allows me to do just that. It’s like putting together a puzzle with high stakes: aligning regulatory requirements, technical constraints, and business objectives to create efficient and compliant solutions. The fact that this puzzle-solving contributes to something as meaningful as patient health makes it deeply rewarding.

AG Solution - Digital Transformation Partner for Pharmaceutical Manufacturing AG Solution helps pharmaceutical companies turn regulatory complexity into competitive advantage. Since 2007, we've partnered with industry leaders like Sanofi and AGC Pharma Chemicals to deliver measurable results in highly regulated environments. Our pharmaceutical expertise: - Smart Compliance Integration: Embedding FDA, EMA, and GMP validation directly into digital architecture - End-to-End Traceability: Complete visibility from raw materials to patient delivery - OT Cybersecurity: Purpose-built protection for critical pharmaceutical infrastructure - Process Optimization: AI-driven insights that enhance efficiency while maintaining regulatory integrity We don't just implement technology—we align it with your regulatory strategy. Our approach transforms compliance from a cost center into a performance driver, helping pharmaceutical manufacturers achieve both operational excellence and regulatory confidence. Proven results: Reduced compliance costs, faster time-to-market, and enhanced operational resilience across global pharmaceutical operations.